CHARACTERISTICS OF COGNITIVE AND PSYCHIATRIC DISORDERS AMONG PARKINSON PATIENTS WITH HYPERTENSION

Viết Lực Trần1,2,, Ngọc Tâm Nguyễn1,2, Xuân Thanh Nguyễn1,2
1 HMU
2 National Geriatric Hospital

Main Article Content

Abstract

Objectives: to describe the cognitive and psychiatric disorders among Parkinson patients with hypertension. Subjects and methods: a cross-sectional descriptive study on 50 patients diagnosed Parkinson's disease with hypertension according to the United Kingdom Brain Bank Criteria, 2020 International Society of hypertention Global Hypertention Practice Guidelines. Results: The average age of the participants was 69.38±7.99, male accounted for 56%, female accounted for 44%. In the group of stage 1 hypertension, the percentage of patients with mild dementia showed the majority. While in the group with stage 2 hypertension, patients distributed in all levels of dementia with rates of mild, moderate and severe dementia of 31.8%, 36.4%, 4.5%, respectively. Parkinson's patients with hypertension had disorders related to anxiety, movement disorders, eating disorders accounted for a high rate, 32%, 30%, 22%, respectively. Conclusion: The prevalence of cognitive and mental disorders of Parkinson's patients with hypertension was quite high. Therefore, screening for cognitive and psychiatric disorders in hypertensive Parkinson's patients is essential.

Article Details

References

1. Elan D. Louis, Stephan A. Mayer, Lewis P. Rowland. “Parkinson Disease”, Merritt’s Neurology. Thirteenth.; 2015.
2. Wang X, Zeng F, Jin WS, et al. Comorbidity burden of patients with Parkinson’s disease and Parkinsonism between 2003 and 2012: A multicentre, nationwide, retrospective study in China. Sci Rep. 2017;7(1):1671. doi:10.1038/ s41598-017-01795-0
3. The global epidemiology of hypertension - PMC. Accessed October 2, 2022. https:// www.ncbi.nlm.nih.gov/pmc/articles/PMC7998524/
4. Tulbă D, Cozma L, Bălănescu P, Buzea A, Băicuș C, Popescu BO. Blood Pressure Patterns in Patients with Parkinson’s Disease: A Systematic Review. J Pers Med. 2021;11(2). doi:10.3390/ jpm11020129
5. Tarakad A, Jankovic J. Diagnosis and Management of Parkinson’s Disease. Semin Neurol. 2017;37(02):118-126. doi:10.1055/s-0037-1601888
6. Unger T, Borghi C, Charchar F, et al. 2020 International Society of Hypertension Global Hypertension Practice Guidelines. Hypertension. 2020;75(6):1334-1357. doi:10.1161/HYPERTENSIONAHA.120.15026
7. Perneczky R, Wagenpfeil S, Komossa K, Grimmer T, Diehl J, Kurz A. Mapping Scores Onto Stages: Mini-Mental State Examination and Clinical Dementia Rating. Am J Geriatr Psychiatry. 2006;14(2):139-144. doi:10.1097/01.JGP.0000192478.82189.a8
8. Martínez-Martín P, Forjaz MJ, Frades-Payo B, et al. Caregiver burden in Parkinson’s disease. Mov Disord Off J Mov Disord Soc. 2007; 22(7): 924-931; quiz 1060. doi:10.1002/mds.21355
9. Tysnes OB, Storstein A. Epidemiology of Parkinson’s disease. J Neural Transm Vienna Austria 1996. 2017;124(8):901-905. doi:10.1007/ s00702-017-1686-y
10. Galvin JE. Cognitive change in Parkinson disease. Alzheimer Dis Assoc Disord. 2006;20(4):302-310. doi:10.1097/01.wad.0000213858.27731.f8